Related Experiment Video
Updated: Feb 10, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease
Linda M Shecterle1, Kathleen R Terry1, John A St Cyr1
1Research and Development, Jacqmar, Inc.
Insights
Cardiovascular disease, including atherosclerosis, impairs heart energy production. D-ribose may help restore adenosine triphosphate (ATP) levels, improving heart function after ischemia.
Area of Science:
- Cardiology
- Biochemistry
- Metabolic Research
Background:
- Cardiovascular disease is a leading global cause of death.
- Atherosclerosis progression is influenced by genetics and lifestyle.
- Myocardial ischemia, common in atherosclerosis, reduces cellular adenosine triphosphate (ATP) levels, impairing heart function.
Purpose of the Study:
- To review ischemic cardiovascular disease.
- To explore the potential role of D-ribose in improving myocardial energy metabolism.
- To assess D-ribose's benefits for heart function following ischemia.
Main Methods:
- Literature review of ischemic cardiovascular disease.
- Analysis of studies on D-ribose and cellular energy levels.
- Evaluation of pre-clinical and clinical data on D-ribose efficacy.
Main Results:
- D-ribose is a naturally occurring carbohydrate.
- Pre-clinical studies suggest D-ribose increases cellular ATP levels.
- Clinical evaluations indicate potential benefits of D-ribose in ischemia.
Conclusions:
- D-ribose shows promise in restoring myocardial ATP levels.
- D-ribose may improve cardiac function in ischemic conditions.
- Further research into D-ribose for cardiovascular health is warranted.
Abstract:
Cardiovascular disease still remains the leading cause of deaths worldwide. Atherosclerosis, the most common type of cardiovascular disease, has continued to progress due to many factors, genetics, and lifestyles. All cells require adequate adenosine triphosphate (ATP) levels to maintain their integrity and function. Myocardial ischemia commonly found in atherosclerosis can produce lower levels of ATP, which affects not only cellular energy, but also alters normal function. D-ribose, a naturally occurring pentose carbohydrate, has been shown to increase cellular energy levels and improve function following ischemia in pre-clinical studies and have demonstrated potential benefits in clinical evaluations. This review paper presents an overview of ischemic cardiovascular disease and the potential role that D-ribose could play in improving myocardial energy levels and function in the area of ischemic cardiovascular diseases.
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Benefits of Self-Esteem
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...